{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:56:40Z","timestamp":1768478200469,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000980","name":"Arthritis Foundation","doi-asserted-by":"crossref","award":["innovative research grant"],"award-info":[{"award-number":["innovative research grant"]}],"id":[{"id":"10.13039\/100000980","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CARRA","award":["publication grant"],"award-info":[{"award-number":["publication grant"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12969-019-0350-5","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T12:48:10Z","timestamp":1563194890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study"],"prefix":"10.1186","volume":"17","author":[{"name":"For the CARRA Registry Investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8276-2866","authenticated-orcid":false,"given":"Suzanne C.","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0911-9310","authenticated-orcid":false,"given":"Robert C.","family":"Fuhlbrigge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald M.","family":"Laxer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Pope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria F.","family":"Ibarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"Thomas","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara L.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandy","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Dedeoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn S.","family":"Torok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Egla","family":"Rabinovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Polly J.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilynn","family":"Punaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian M.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria C.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"key":"350_CR1","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1002\/art.27670","volume":"62","author":"N Ruperto","year":"2010","unstructured":"Ruperto N, Giannini E, Pistorio A, Brunner H, Martini A, Lovell D. Is it time to move to active comparator trials in juvenile idiopathic arthritis?: a review of current study designs. Arthritis Rheum. 2010;62:3131\u20139.","journal-title":"Arthritis Rheum"},{"key":"350_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nrrheum.2013.105","volume":"9","author":"D Lovell","year":"2013","unstructured":"Lovell D, Ruperto N, Giannini E, Martini A. Advances from clinical trials in juvenile idiopathic arthritis. Nat Rev Rheumatol. 2013;9:557\u201363.","journal-title":"Nat Rev Rheumatol"},{"key":"350_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/art.40395","volume":"70","author":"S Ringold","year":"2018","unstructured":"Ringold S, Nigrovic P, Feldman B, Tomlinson G, von Scheven E, Wallace C, et al. The childhood arthritis and rheumatology research Alliance consensus treatment plans: toward comparative effectiveness in the pediatric rheumatic diseases. Arthritis Rheumatol. 2018;70:669\u201378.","journal-title":"Arthritis Rheumatol"},{"key":"350_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s40272-017-0244-2","volume":"19","author":"S Balevic","year":"2017","unstructured":"Balevic S, Becker M, Cohen-Wolkowiez M, Schanberg L. Clinical trial Design in Juvenile Idiopathic Arthritis. Pediatr Drugs. 2017;19:379\u201389.","journal-title":"Pediatr Drugs"},{"key":"350_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/acr.20070","volume":"62","author":"A Herrick","year":"2010","unstructured":"Herrick A, Ennis H, Bhushan M, Silman A, Baildam E. Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland. Arthritis Care Res. 2010;62:213\u20138.","journal-title":"Arthritis Care Res"},{"key":"350_CR6","first-page":"73","volume":"24","author":"L Peterson","year":"1997","unstructured":"Peterson L, Nelson A, Su W, Mason T, O'Fallon W, Gabriel S. The epidemiology of morphea (localized scleroderma) in Olmstead County 1960-1993. J Rheumatol. 1997;24:73\u201380.","journal-title":"J Rheumatol"},{"key":"350_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12969-017-0160-6","volume":"15","author":"T Beukelman","year":"2017","unstructured":"Beukelman T, Kimura Y, Ilowite N, Mieszkalski K, Natter M, Burrell G, et al. The new childhood arthritis and rheumatology research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months. Pediatr Rheumatol Online J. 2017;15:30.","journal-title":"Pediatr Rheumatol Online J"},{"key":"350_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/acr2.1019","volume":"1","author":"E Wu","year":"2019","unstructured":"Wu E, Li S, Torok K, Virkud Y, Fuhlbrigge R, Rabinovich E, et al. Baseline description of the juvenile localized scleroderma subgroup from the childhood arthritis and rheumatology research Alliance legacy registry. ACR Open Rheumatol. 2019;1:119\u201324.","journal-title":"ACR Open Rheumatol"},{"key":"350_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12969-017-0157-1","volume":"15","author":"Y Kimura","year":"2017","unstructured":"Kimura Y, Grevich S, Beukelman T, Morgan E, Nigrovic PA, Mieszkalski K, et al. Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic juvenile idiopathic arthritis consensus treatment plans. Pediatr Rheumatol Online J. 2017;15:23.","journal-title":"Pediatr Rheumatol Online J"},{"key":"350_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12969-018-0279-0","volume":"16","author":"JC Cooper","year":"2018","unstructured":"Cooper JC, Rouster-Stevens K, Wright TB, Hsu JJ, Klein-Gitelman MS, Ardoin SP, et al. Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis. Pediatr Rheumatol Online J. 2018;16:65.","journal-title":"Pediatr Rheumatol Online J"},{"key":"350_CR11","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1002\/art.21264","volume":"52","author":"F Zulian","year":"2005","unstructured":"Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J, et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum. 2005;52:2873\u201381.","journal-title":"Arthritis Rheum"},{"key":"350_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.pcl.2012.03.011","volume":"59","author":"KS Torok","year":"2012","unstructured":"Torok KS. Pediatric scleroderma: systemic or localized forms. Pediatr Clin N Am. 2012;59:381\u2013405.","journal-title":"Pediatr Clin N Am"},{"key":"350_CR13","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.pcl.2018.04.002","volume":"65","author":"SC Li","year":"2018","unstructured":"Li SC. Scleroderma in children and adolescents: localized scleroderma and systemic sclerosis. Pediatr Clin N Am. 2018;65:757\u201381.","journal-title":"Pediatr Clin N Am"},{"key":"350_CR14","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.3899\/jrheum.081284","volume":"36","author":"T Arkachaisri","year":"2009","unstructured":"Arkachaisri T, Vilaiyuk S, Li S, O'Neil KM, Pope E, Higgins GC, et al. The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures. J Rheumatol. 2009;36:2819\u201329.","journal-title":"J Rheumatol"},{"key":"350_CR15","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1136\/ard.2006.066530","volume":"66","author":"L Czirj\u00e1k","year":"2007","unstructured":"Czirj\u00e1k L, Nagy Z, Aringer M, Riemekasten G, Matucci-Cerinic M, Furst D, et al. The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rheum Dis. 2007;66:966\u20139.","journal-title":"Ann Rheum Dis"},{"key":"350_CR16","doi-asserted-by":"publisher","first-page":"e2696","DOI":"10.1371\/journal.pone.0002696","volume":"3","author":"A Milano","year":"2008","unstructured":"Milano A, Pendergrass SA, Sargent JL, George LK, McCalmont TH, Connolly MK, et al. Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One. 2008;3:e2696.","journal-title":"PLoS One"},{"key":"350_CR17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jid.2018.09.025","volume":"139","author":"E Mirizio","year":"2019","unstructured":"Mirizio E, Marathi A, Hershey N, Ross C, Schollaert K, Salgado C, et al. Identifying the signature immune phenotypes present in pediatric localized scleroderma. J Invest Dermatol. 2019;139:715\u20138.","journal-title":"J Invest Dermatol"},{"key":"350_CR18","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/art.30264","volume":"63","author":"F Zulian","year":"2011","unstructured":"Zulian F, Martini G, Vallongo C, Vittadello F, Falcini F, Patrizi A, et al. Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2011;63:1998\u20132006.","journal-title":"Arthritis Rheum"},{"key":"350_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3899\/jrheum.090708","volume":"37","author":"SC Li","year":"2010","unstructured":"Li SC, Feldman BM, Higgins GC, Haines KA, Punaro MG, O'Neil KM. Treatment of pediatric localized scleroderma: results of a survey of north American pediatric rheumatologists. J Rheumatol. 2010;37:175\u201381.","journal-title":"J Rheumatol"},{"key":"350_CR20","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/acr.21687","volume":"64","author":"SC Li","year":"2012","unstructured":"Li SC, Torok KS, Pope E, Dedeoglu F, Hong S, Jacobe HT, et al. Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res (Hoboken). 2012;64:1175\u201385.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"350_CR21","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1002\/sim.4780141709","volume":"14","author":"R Browne","year":"1995","unstructured":"Browne R. On the use of a pilot sample for sample size determination. Stat Med. 1995;14:1933\u201340.","journal-title":"Stat Med"},{"key":"350_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j..2002.384.doc.x","volume":"10","author":"G Lancaster","year":"2004","unstructured":"Lancaster G, Dodd S, Williamson P. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Practice. 2004;10:307\u201312.","journal-title":"J Eval Clin Practice"},{"key":"350_CR23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","volume":"18","author":"RM Laxer","year":"2006","unstructured":"Laxer RM, Zulian F. Localized scleroderma. Curr Opin Rheumatol. 2006;18:606\u201313.","journal-title":"Curr Opin Rheumatol"},{"key":"350_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/jdv.13790","volume":"31","author":"A Lis-Swiety","year":"2017","unstructured":"Lis-Swiety A, Janicka I, Skrzypek-Salamon A, Brzezinska-Wcislo L. A systematic review of tools for determining activity of localized scleroderma in paediatric and adult patients. J Eur Acad Dermatol Venereol. 2017;31:30\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"350_CR25","first-page":"406-417.e4","volume-title":"Textbook of Pediatric Rheumatology","author":"Suzanne C. Li","year":"2016","unstructured":"Li S, Pope E. Localized Scleroderma. In: Petty R, Laxer R, Lindsley C, editors. Cassidy's Textbook of Pediatric Rheumatology. 7th ed. Philadelphia: Elsevier; 2016. p. 406\u201317."},{"key":"350_CR26","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3899\/jrheum.080098","volume":"35","author":"T Arkachaisri","year":"2008","unstructured":"Arkachaisri T, Pino S. Localized scleroderma severity index and global assessments: a pilot study of outcome instruments. J Rheumatol. 2008;35:650\u20137.","journal-title":"J Rheumatol"},{"key":"350_CR27","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jaad.2013.02.007","volume":"69","author":"CE Kelsey","year":"2013","unstructured":"Kelsey CE, Torok KS. The localized scleroderma cutaneous assessment tool: responsiveness to change in a pediatric clinical population. J Am Acad Dermatol. 2013;69:214\u201320.","journal-title":"J Am Acad Dermatol"},{"key":"350_CR28","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3899\/jrheum.171381","volume":"12","author":"SC Li","year":"2018","unstructured":"Li SC, Li X, Pope E, Stewart K, Higgins GC, Rabinovich CE, et al. New features for measuring disease activity in pediatric localized scleroderma. J Rheumatol. 2018;12:1680\u20138.","journal-title":"J Rheumatol"},{"key":"350_CR29","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3899\/jrheum.110210","volume":"39","author":"KS Torok","year":"2012","unstructured":"Torok KS, Arkachaisri T. Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study. J Rheumatol. 2012;39:286\u201394.","journal-title":"J Rheumatol"},{"key":"350_CR30","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","volume":"39","author":"JW Varni","year":"2001","unstructured":"Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39:800.","journal-title":"Med Care"},{"key":"350_CR31","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/art.10095","volume":"46","author":"J Varni","year":"2002","unstructured":"Varni J, Seid M, Smith Knight T, Burwinkle T, Brown J, Szer IS. The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the pediatric quality of life inventory generic Core scales and rheumatology module. Arthritis Rheum. 2002;46:714.","journal-title":"Arthritis Rheum"},{"key":"350_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1477-7525-2-55","volume":"2","author":"J Varni","year":"2004","unstructured":"Varni J, Sherman S, Burwinkle T, Dickinson P, Dixon P. The PedsQL family impact module: preliminary reliability and validity. Health Qual Life Outcomes. 2004;2:55.","journal-title":"Health Qual Life Outcomes"},{"key":"350_CR33","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/art.1780371209","volume":"37","author":"G Singh","year":"1994","unstructured":"Singh G, Athreya B, Fries J, Goldsmith D. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1994;37:1761.","journal-title":"Arthritis Rheum"},{"key":"350_CR34","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1365-2133.1995.tb16953.x","volume":"132","author":"M Lewis-Jones","year":"1995","unstructured":"Lewis-Jones M, Finlay A. The Children's dermatology life quality index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132:942\u20139.","journal-title":"Br J Dermatol"},{"key":"350_CR35","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1002\/art.24034","volume":"58","author":"JM Dalrymple","year":"2008","unstructured":"Dalrymple JM, Stamp LK, O'Donnell JL, Chapman PT, Zhang M, Barclay ML. Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 2008;58:3299\u2013308.","journal-title":"Arthritis Rheum"},{"key":"350_CR36","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/j.1399-3046.2005.00386.x","volume":"9","author":"R Ettenger","year":"2005","unstructured":"Ettenger R, Bartosh S, Choi L, Zhu W, Niederberger W, Campestrini J, et al. Pharmacokinetics of enteric-coated mycophenolate sodium in stable pediatric renal transplant recipients. Pediatr Transplant. 2005;9:780\u20137.","journal-title":"Pediatr Transplant"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-019-0350-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-019-0350-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-019-0350-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T23:45:23Z","timestamp":1721519123000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-019-0350-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["350"],"URL":"https:\/\/doi.org\/10.1186\/s12969-019-0350-5","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,15]]},"assertion":[{"value":"30 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Each participating site (<i>n<\/i>\u00a0=\u200910) obtained institutional Review Board (Ethics committee) approval for both the study itself and the informed consent form, which included our intent to publish the results of the study and measures to protect confidentiality. Informed consent\/assent was obtained per site protocol, and no compensation was given to participants. The written consent form was signed by either the patient, or by the patient\u2019s parent\/guardian with written or verbal assent of the patient as appropriate for age. Data identified only by subject number were analyzed at Hackensack University Medical Center, the coordinating center, under ethics approval number for Pro00001481.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Included in parent\/patient consent for study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}